BigTrunk Communications has been awarded the digital marketing mandate for Soframycin, an antiseptic cream from the Encube Ethicals portfolio. The partnership marks Soframycin’s entry into the digital space, with the aim of expanding its reach across India through social media and data-driven campaigns.
The mandate covers digital strategy and execution, with an emphasis on connecting Soframycin’s brand heritage with a contemporary, health-focused audience.
Encube Ethicals, which has a presence in over 50 countries, is known for its work in topical formulations. The company will now work with BigTrunk to develop digital communications for Soframycin.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Ajay Rawal, Vice President – Marketing, Soframycin.
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added Bharat Subramaniam, Founder & Managing Director of BigTrunk Communications. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
